Ifidancitinib

CAS No. 1236667-40-5

Ifidancitinib( —— )

Catalog No. M35053 CAS No. 1236667-40-5

Ifidancitinib (ATI-50002) is a specific JAK kinase 1/3 inhibitor that induces hair growth in AA-affected C3H/HeJ mice.Ifidancitinib can be used to study autoimmune diseases.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 226 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Ifidancitinib
  • Note
    Research use only, not for human use.
  • Brief Description
    Ifidancitinib (ATI-50002) is a specific JAK kinase 1/3 inhibitor that induces hair growth in AA-affected C3H/HeJ mice.Ifidancitinib can be used to study autoimmune diseases.
  • Description
    Ifidancitinib (ATI-50002) is a potent and selective inhibitor of JAK kinases 1/3. Ifidancitinib can be used in studies of allergies, asthma and autoimmune diseases.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Angiogenesis
  • Target
    JAK
  • Recptor
    JAK
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1236667-40-5
  • Formula Weight
    395.39
  • Molecular Formula
    C20H18FN5O3
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 62.5 mg/mL (158.07 mM; Ultrasonic )
  • SMILES
    COc1cc(Nc2ncc(C)c(Nc3ccc4oc(=O)[nH]c4c3)n2)cc(C)c1F
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Li, Hui; Heckrodt, Thilo J.; Chen, Yan; Mcmurtrie, Darren John; Taylor, Vanessa; Singh, Rajinder; Ding, Pingyu; Yen, Rose.Preparation of phenylaminopyrimidinylaminooxobenzooxazole derivatives for use as JAK kinase inhibitors. WO2012015972A1
molnova catalog
related products
  • AZD 4205

    AZD 4205 (AZD4205) is a potent, selective JAK1 inhibitor IC50 of 73 nM and Ki of 2.8 nM, shows high selectivity against JAK2 and JAK3 with IC50 of 13,233 nM and >30,000 nM respectively.

  • TG-101209

    A potent, selective, orally bioavailable JAK2 inhibitor with IC50 of 6 nM; also inhibits FLT3 (IC50=25 nM) and RET (IC50=17 nM) kinases, weakly inhibits JAK3 (IC50=168 nM).

  • AS 2553627

    AS 2553627 (AS2553627)?is a novel potent, selective pan-JAK inhibitor.